GlassScriptPhysician profile
Sunil S Nair
NPI 1861831018
$1,653.23
in general payments reported to CMS, 2019-2025
17 companies · $169 in 2025
The $169 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $260 · 2020: $86.40 · 2021: $171 · 2022: $213 · 2023: $405 · 2024: $349 · 2025: $169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $906 · Education: $17.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $905.87 |
| Education | $17.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $459.46 | 2020-2024 | Wakix |
| Jazz Pharmaceuticals INC. | $269.28 | 2021-2024 | Xywav |
| Genentech USA, INC. | $248.86 | 2019 | |
| Merck Sharp & Dohme LLC | $89.76 | 2023-2025 | Belsomra, Zerbaxa, Winrevair |
| Astrazeneca Pharmaceuticals LP | $87.56 | 2023-2025 | Airsupra, Breztri, Symbicort |
| Inspire Medical Systems, INC. | $84.75 | 2023-2025 | Inspire |
| Axsome Therapeutics, INC. | $83.74 | 2023 | Sunosi |
| Avadel Cns Pharmaceuticals, LLC | $63.73 | 2023-2024 | Lumryz |
| Glaxosmithkline, LLC. | $62.40 | 2023-2025 | Nucala |
| Alexion Pharmaceuticals, INC. | $49.58 | 2024-2025 | Ultomiris |
| Insmed, INC. | $38.50 | 2025 | Brinsupri, Arikayce |
| Amgen INC. | $27.64 | 2023 | Tezspire |
| Regeneron Healthcare Solutions, INC. | $23.50 | 2024 | Dupixent |
| Mylan Specialty L.P. | $21.16 | 2024 | Yupelri |
| Resmed Corp | $19.27 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $13.10 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $10.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunil Nair listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.